Ultralife (NASDAQ:ULBI) CEO Purchases 2,000 Shares

Ultralife Corporation (NASDAQ:ULBI) CEO Michael Edward Manna acquired 2,000 shares of the stock in a transaction on Thursday, March 12th. The stock was bought at an average price of $6.01 per share, with a total value of $12,020.00. Following the transaction, the chief executive officer directly owned 26,874 shares in the company, valued at approximately $161,512.74. This represents a 8.04% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Ultralife Price Performance

Shares of ULBI stock traded up $0.46 during trading hours on Monday, reaching $7.01. 136,346 shares of the company were exchanged, compared to its average volume of 49,284. Ultralife Corporation has a fifty-two week low of $4.07 and a fifty-two week high of $9.52. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.99 and a quick ratio of 1.42. The stock’s fifty day moving average is $6.15 and its two-hundred day moving average is $6.27. The company has a market cap of $116.72 million, a price-to-earnings ratio of -19.47 and a beta of 0.88.

Ultralife (NASDAQ:ULBI) last issued its quarterly earnings results on Tuesday, March 10th. The technology company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.12). Ultralife had a negative net margin of 3.09% and a positive return on equity of 3.06%. The company had revenue of $48.48 million during the quarter, compared to analyst estimates of $57.00 million.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Ultralife in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Ultralife currently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Truffle Hound Capital LLC acquired a new stake in shares of Ultralife during the second quarter worth $2,245,000. RBF Capital LLC bought a new position in Ultralife during the second quarter worth about $2,020,000. Arrowstreet Capital Limited Partnership boosted its holdings in Ultralife by 210.8% during the third quarter. Arrowstreet Capital Limited Partnership now owns 219,018 shares of the technology company’s stock worth $1,494,000 after buying an additional 148,542 shares during the last quarter. Teton Advisors LLC acquired a new position in shares of Ultralife during the 3rd quarter worth about $752,000. Finally, Rothschild Wealth LLC bought a new stake in shares of Ultralife in the 4th quarter valued at about $400,000. 30.68% of the stock is currently owned by institutional investors.

About Ultralife

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.